-
Something wrong with this record ?
International monitoring of capacity of treatment systems for alcohol and drug use disorders: Methodology of the Service Capacity Index for Substance Use Disorders
D. Krupchanka, T. Formanek, K. Shield, J. Rehm, MW. Heymans, A. Fleischmann, L. Degenhardt, T. Gawad, V. Poznyak
Language English Country United States
Document type Journal Article
Grant support
001
World Health Organization - International
NLK
Directory of Open Access Journals
from 2020
PubMed Central
from 1998
ProQuest Central
from 2022-01-01
Medline Complete (EBSCOhost)
from 2003-03-01
Psychology Database (ProQuest)
from 2022-01-01
Wiley-Blackwell Open Access Titles
from 2020
PubMed
36564954
DOI
10.1002/mpr.1950
Knihovny.cz E-resources
- MeSH
- Ethanol MeSH
- Humans MeSH
- Substance-Related Disorders * epidemiology therapy MeSH
- Surveys and Questionnaires MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: We aimed to develop a Service Capacity Index for Substance Use Disorders (SCI-SUD) that would reflect the capacity of national health systems to provide treatment for alcohol and drug use disorders, in terms of the proportion of available service elements in a given country from a theoretical maximum. METHODS: Data were collected through the WHO Global Survey on Progress with Sustainable Development Goals (SDG) Health Target 3.5, conducted between December 2019 and July 2020 to produce the SCI-SUD, based on 378 variables overall. RESULTS: The SCI-SUD was directly derived for 145 countries. We used multiple imputation to produce comparable SCI-SUD estimates for countries that did not submit data (40 countries) or had very high level of missingness (9 countries). The final SCI-SUD demonstrates considerable consistency and internal stability and is strongly associated with the macro-level economic, healthcare-related and epidemiologic (such as prevalence rates) variables. CONCLUSION: The presented methodology represents a step forward in monitoring the global situation in regard to the development of treatment systems for SU disorders, however, further work is warranted to improve the external validity of the measure (e.g., in-depth data generation in countries) and ensure its feasibility for regular reporting (e.g., reducing the number of variables).
Department of Psychiatry University of Cambridge Cambridge UK
Department of Public Mental Health National Institute of Mental Health Klecany Czech Republic
National Drug and Alcohol Research Centre University of New South Wales Sydney Australia
National Rehabilitation Centre Abu Dhabi United Arab Emirates
PAHO WHO Collaborating Centre at CAMH Toronto Ontario Canada
Psychiatry Department Faculty of Medicine Cairo University Giza Egypt
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016464
- 003
- CZ-PrNML
- 005
- 20240626152743.0
- 007
- ta
- 008
- 231013s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/mpr.1950 $2 doi
- 035 __
- $a (PubMed)36564954
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Krupchanka, Dzmitry $u Department of Mental Health and Substance Use, Alcohol, Drugs and Addictive Behaviours Unit, World Health Organization, Geneva, Switzerland $1 https://orcid.org/0000000301265281
- 245 10
- $a International monitoring of capacity of treatment systems for alcohol and drug use disorders: Methodology of the Service Capacity Index for Substance Use Disorders / $c D. Krupchanka, T. Formanek, K. Shield, J. Rehm, MW. Heymans, A. Fleischmann, L. Degenhardt, T. Gawad, V. Poznyak
- 520 9_
- $a OBJECTIVES: We aimed to develop a Service Capacity Index for Substance Use Disorders (SCI-SUD) that would reflect the capacity of national health systems to provide treatment for alcohol and drug use disorders, in terms of the proportion of available service elements in a given country from a theoretical maximum. METHODS: Data were collected through the WHO Global Survey on Progress with Sustainable Development Goals (SDG) Health Target 3.5, conducted between December 2019 and July 2020 to produce the SCI-SUD, based on 378 variables overall. RESULTS: The SCI-SUD was directly derived for 145 countries. We used multiple imputation to produce comparable SCI-SUD estimates for countries that did not submit data (40 countries) or had very high level of missingness (9 countries). The final SCI-SUD demonstrates considerable consistency and internal stability and is strongly associated with the macro-level economic, healthcare-related and epidemiologic (such as prevalence rates) variables. CONCLUSION: The presented methodology represents a step forward in monitoring the global situation in regard to the development of treatment systems for SU disorders, however, further work is warranted to improve the external validity of the measure (e.g., in-depth data generation in countries) and ensure its feasibility for regular reporting (e.g., reducing the number of variables).
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a poruchy spojené s užíváním psychoaktivních látek $x epidemiologie $x terapie $7 D019966
- 650 _2
- $a ethanol $7 D000431
- 650 _2
- $a průzkumy a dotazníky $7 D011795
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Formánek, Tomáš $u Department of Public Mental Health, National Institute of Mental Health, Klecany, Czech Republic $u Department of Psychiatry, University of Cambridge, Cambridge, UK $7 xx0319355
- 700 1_
- $a Shield, Kevin $u Institute for Mental Health Policy Research & Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada $u Management and Evaluation; & Department of Psychiatry, Dalla Lana School of Public Health, Institute of Health Policy, University of Toronto (UofT), Toronto, Ontario, Canada $u PAHO/WHO Collaborating Centre at CAMH, Toronto, Ontario, Canada
- 700 1_
- $a Rehm, Jürgen $u Institute for Mental Health Policy Research & Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada $u Management and Evaluation; & Department of Psychiatry, Dalla Lana School of Public Health, Institute of Health Policy, University of Toronto (UofT), Toronto, Ontario, Canada $u PAHO/WHO Collaborating Centre at CAMH, Toronto, Ontario, Canada
- 700 1_
- $a Heymans, Martijn W $u Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands
- 700 1_
- $a Fleischmann, Alexandra $u Department of Mental Health and Substance Use, Alcohol, Drugs and Addictive Behaviours Unit, World Health Organization, Geneva, Switzerland
- 700 1_
- $a Degenhardt, Louisa $u National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
- 700 1_
- $a Gawad, Tarek $u National Rehabilitation Centre, Abu Dhabi, United Arab Emirates $u Psychiatry Department, Faculty of Medicine, Cairo University, Giza, Egypt
- 700 1_
- $a Poznyak, Vladimir $u Department of Mental Health and Substance Use, Alcohol, Drugs and Addictive Behaviours Unit, World Health Organization, Geneva, Switzerland
- 773 0_
- $w MED00007982 $t International journal of methods in psychiatric research $x 1557-0657 $g Roč. 32, č. 3 (2023), s. e1950
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36564954 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20240626152738 $b ABA008
- 999 __
- $a ok $b bmc $g 2000158 $s 1202826
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 32 $c 3 $d e1950 $e 20221223 $i 1557-0657 $m International journal of methods in psychiatric research $n Int J Methods Psychiatr Res $x MED00007982
- GRA __
- $a 001 $p World Health Organization $2 International
- LZP __
- $a Pubmed-20231013